# BioAgilytix – FDA Inspection, Jun 7, 2019

Source: https://www.keypedia.com/records/fda_inspections/bioagilytix/12e87e4b-ced1-47dd-8f40-ea2c51469eb8
Source feed: FDA_Inspections

> FDA inspection 1097964 of BioAgilytix, June 07, 2019. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097964
- Company Name: BioAgilytix
- Inspection Date: 2019-06-07
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1049402 - 2018-03-02](https://www.keypedia.com/records/fda_inspections/bioagilytix/9062b407-edbe-4d7b-8805-b846563ac74d)

## Related Officers

- Issuing Officer

Company: https://www.keypedia.com/companies/bioagilytix/a4342985-488a-46f4-b266-3d3203abab62

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c